Reducing Nrf2 levels enhances the susceptibility of DN cells to ferroptosis and fenofibrate by upregulating Nrf2 expression and inhibiting ferroptosis, which can decelerate DN progression. This evidence concerns the gene NFE2L2 and liver dysplastic nodule.